The Pharma MSA Insurance Requirements Guide: Translating Sponsor Contract Language into a Compliant Program

The short answer first

A typical pharmaceutical sponsor MSA contains between 12 and 20 distinct insurance requirements compressed into four to seven pages. Most CDMOs reading the section for the first time find that:

• Their products liability limit is $2M shy of what the MSA requires
• Their additional insured endorsement covers ongoing operations but not products and completed operations — the only thing that actually matters for a contract manufacturer
• Their certificate of insurance disclaims the very notice-of-cancellation provision the MSA mandates
• The indemnity clause is not actually negotiated against the insurance limits, leaving company equity exposed beyond the policy

None of these are exotic problems. All are fixable, most are inexpensive, and several are negotiable with the sponsor. This guide walks through the typical clauses, what each one means in plain English, and what to actually do about them.

What sponsors are trying to accomplish

Before you read a single MSA insurance clause, understand the sponsor's perspective: their legal team is not trying to harm you. They are trying to ensure that if a manufacturing-related event causes a loss, the loss flows through your insurance program first, not theirs. That principle — that your insurance is the primary financial backstop for risks arising out of your work — is what every clause is structured to enforce.

Once you understand that intent, the requirements stop looking arbitrary. The $5M products liability requirement is not a number someone made up; it is the sponsor's actuarial best estimate of a typical product-related claim plus a margin. The "primary and non-contributory" language is not legal harassment; it is the sponsor saying "do not let your carrier point at our carrier and start a coverage fight." The waiver of subrogation prevents your insurer from recouping a paid claim from the sponsor, which would functionally undo the protection.

You can negotiate the specific numbers and the specific edge cases. You cannot negotiate the principle. Brokers who try to fight every clause as overreach end up either losing the deal for their client or getting their client stuck with a watered-down version that does not actually satisfy the MSA, surfacing as a compliance crisis a year in.

The clauses, ranked by frequency

1. Commercial general liability — $1M / $2M

"Commercial General Liability insurance with limits of not less than $1,000,000 per occurrence and $2,000,000 in the aggregate."

This is the floor. Almost every sponsor MSA contains this language verbatim. You almost certainly already meet it.

The trap is the aggregate. $2M aggregate sounds adequate until you realize the aggregate is shared across all sponsors, all products, and all claim activity in a policy year. A CDMO with 14 sponsor MSAs, each requiring $2M aggregate, is committing the same $2M aggregate against 14 different obligations. One bad year could exhaust it.

The fix is a "per project" or "per location" general aggregate endorsement. ISO offers CG 25 03 (per project) and CG 25 04 (per location). Either one resets the aggregate per project or location, which is what your sponsors actually need. Carriers charge a small premium for these endorsements but they are routinely available.

What to do: Ask your broker whether your CGL is endorsed with a per-project or per-location aggregate. If not, request a quote. If you have more than five active sponsor MSAs, treat this as a priority renewal item.

2. Products / completed operations — $5M

"Products and Completed Operations coverage with a limit of not less than $5,000,000 per occurrence and in the aggregate, which may be satisfied by a combination of primary and excess/umbrella policies."

This is your single most important coverage as a CDMO. Most CDMOs satisfy the $5M with $1M primary + $4M umbrella. That stack is fine if — and only if — three things are true:

1. Your CGL has products and completed operations coverage with no manufacturing exclusion or restrictive products endorsement
2. Your umbrella schedules products / completed operations as covered underlying
3. Your products and completed operations aggregate is separate from your general aggregate

Verify all three before you assume you are compliant. The most common gap in this segment is an umbrella that says it sits over the CGL but in fact excludes products coverage above the primary. The COI looks compliant. The actual coverage is not.

What to do: Ask your broker for two specific things: a copy of the umbrella's "scheduled underlying" page (showing CGL products / completed ops as a covered underlying), and confirmation that products / completed ops aggregate is separate from general aggregate on the primary.

3. Additional insured — products and completed operations

"Sponsor and its affiliates shall be named as additional insureds on a primary and non-contributory basis with respect to ongoing operations and the products and completed operations hazard."

Most "blanket" additional insured endorsements on standard CGL policies cover ongoing operations and exclude products / completed ops. For a contract manufacturer, products is the entire revenue line. The endorsement that matters is the one that extends additional insured status to products and completed ops, typically ISO CG 20 37 or a manuscript equivalent. This is a separate endorsement from CG 20 33 (the most common blanket AI for ongoing operations).

This is the most common compliance gap we see when auditing CDMO programs against sponsor MSAs.

What to do: Read your CGL declarations and find the AI endorsement form number. If it is CG 20 33 or similar without a CG 20 37 attached, you are non-compliant for any sponsor requiring AI for products. Most carriers can add CG 20 37 mid-term, often at no premium for a blanket version.

4. Primary and non-contributory

"Manufacturer's insurance shall be primary and non-contributory with respect to any insurance maintained by Sponsor."

This says: if both your insurance and the sponsor's insurance could respond to the same claim, yours pays first and pays without seeking contribution from theirs.

Standard CGL forms have, since 2013, included a "primary and non-contributory" trigger as part of the additional insured endorsement when required by written contract. So if your AI endorsement is current ISO language and the MSA explicitly requires P&NC in writing, you are likely compliant.

What to do: Verify the AI endorsement language includes the P&NC provision triggered by written contract. If your endorsement is older or non-standard, request the carrier add a P&NC endorsement.

5. Waiver of subrogation

"Manufacturer waives all rights of subrogation against Sponsor under all insurance policies required hereunder."

Subrogation is the right of an insurer, after paying a claim, to step into the insured's shoes and pursue recovery from a third party. A waiver of subrogation says your insurer agrees not to do that against the sponsor.

The mechanical fix is a blanket waiver of subrogation endorsement on each required policy: CGL, Auto, Workers Compensation, and Umbrella. For workers compensation, the waiver typically requires a small premium charge per NCCI rules. For the others, it is usually included in a blanket endorsement or available for a small fee.

What to do: Ask your broker to confirm a blanket waiver is in place on every policy listed in the MSA. Pay attention to the WC waiver specifically — it is often forgotten.

6. 30-day notice of cancellation

"Manufacturer shall provide Sponsor with at least thirty (30) days' prior written notice of cancellation, non-renewal, or material modification of any required policy (ten (10) days for non-payment of premium)."

Modern insurance carriers do not, by default, issue cancellation notices to certificate holders. Your COI has a disclaimer that reads something like "should any of the above described policies be cancelled before the expiration date thereof, notice will be delivered in accordance with the policy provisions." That is not a 30-day notice commitment. It is a "we'll do whatever the policy says, which is probably nothing for you, the certificate holder."

True compliance requires either a manuscript endorsement (rare and expensive) or — far more commonly — a contractual commitment from your broker to provide notice on the carrier's behalf. The latter is how most agencies handle this in practice.

What to do: Ask your broker whether they will provide written confirmation that they will give the sponsor 30 days' notice if any policy is at risk of cancellation, non-renewal, or material modification. This is a standard request and most agencies will accommodate it. If yours will not, that is a meaningful tell.

7. The indemnity clause

"Manufacturer shall indemnify, defend, and hold harmless Sponsor and its affiliates from any and all claims, losses, damages, liabilities, costs, and expenses arising out of or related to Manufacturer's performance under this Agreement."

This is where the heaviest negotiation belongs. Read the verb structure: a one-way indemnity in favor of the sponsor for any and all claims arising out of or related to manufacturer performance is functionally unlimited liability for the manufacturer.

Push for these structural changes in negotiation:

1. Mutual indemnity — each party indemnifies the other for the other's negligence
2. Trigger limited to negligence or willful misconduct, not strict liability
3. Carve-outs for sponsor-supplied materials, sponsor specifications, sponsor-directed manufacturing changes, and sponsor regulatory submissions
4. Cap aligned to insurance limits with carve-outs only for gross negligence, willful misconduct, and IP infringement

Few sponsors will accept all four. Most reasonable sponsors will accept some combination of two or three. The version you should never sign is one-way, uncapped, and triggered by anything other than your own fault.

This is a legal negotiation, not an insurance negotiation. Bring your counsel into it. We will support the discussion with the insurance side — confirming what your policy actually covers and what falls outside coverage — but the contract drafting belongs to a lawyer.

8. The "everything else" cluster

The remaining clauses fall into a cluster that is mostly mechanical compliance:

• Workers compensation — statutory + $1M employers liability. Standard. If you are a Texas non-subscriber, this is the moment that ends.
• Commercial auto — $1M CSL. Standard. Watch for hired/non-owned auto if you do not own vehicles; the MSA will still require it.
• Cyber liability — $1M to $5M. Increasingly required since 2023. Application is now extensive (MFA, EDR, backup, vendor management). Start the renewal cycle 90 days before MSA execution.
• Cargo / warehouseman's legal liability. Required if you hold sponsor materials. Limit should match the highest-value sponsor inventory you ever have on hand.
• Carrier rating — A.M. Best A- VII or better. Easy compliance with admitted markets. Watch for non-admitted/surplus lines on hard-to-place coverages.
• Occurrence form for liability. Standard CGL is occurrence-form. Cyber and E&O are typically claims-made — push back if the MSA tries to require occurrence form for those.

A scorecard you can use

If you want a structured way to walk through your own MSA before talking to a broker, the table below is the framework we use internally:

| # | Clause | Compliance check | Common fix | |---|---|---|---| | 1 | CGL $1M/$2M | Aggregate limit ≥ $2M, with per-project endorsement if multi-sponsor | CG 25 03 / CG 25 04 | | 2 | Products $5M | Total stack ≥ $5M, umbrella schedules products | Increase umbrella, verify schedule | | 3 | AI products / completed ops | CG 20 37 or manuscript equivalent | Add CG 20 37 | | 4 | Primary and non-contributory | Triggered by written contract, included in current ISO AI form | Verify endorsement vintage | | 5 | Waiver of subrogation | Blanket waiver on CGL, Auto, WC, Umbrella | Add blanket endorsements | | 6 | 30-day notice of cancellation | Broker contractual commitment to provide notice | Written broker letter | | 7 | Indemnity | Mutual or capped at insurance, with carve-outs | Legal redline | | 8 | WC + EL $1M | Required even for Texas non-subscribers | Buy WC if non-subscriber | | 9 | Auto $1M CSL | Symbol 1 or hired/non-owned where applicable | Verify symbol coverage | | 10 | Cyber $1M-$5M | Limits + application sufficiency | Renew with adequate limits | | 11 | Cargo / warehouseman's | Limit matches max sponsor inventory | Adjust limit at renewal | | 12 | A.M. Best A- VII | All carriers in compliance | Verify each carrier | | 13 | Occurrence form | CGL on occurrence (standard) | Verify form |

A "yes" on every row in this table puts you in compliance with roughly 90% of pharmaceutical sponsor MSAs we see. The remaining 10% includes specialty asks (clinical trial liability, recall coverage limits, drug master file data security clauses) that are sponsor-specific.

Related glossary entries: Commercial General Liability $1M/$2M · Products & Completed Operations $5M · Cyber Liability $3M · Recall Coverage

What this looks like in practice

A typical CDMO program rebuild — moving a $20M revenue oral solid dose contract manufacturer from a generalist manufacturers package to a life-sciences-specific program — usually runs:

• Premium delta: +10% to +25% for the same coverage in a properly underwritten program (sometimes flat or lower if the prior placement was overpriced for the segment)
• Endorsements added: between four and eight, including CG 20 37, blanket waivers, per-project aggregate, P&NC verification, and notice of cancellation broker letter
• Time from quote to bind: 30 to 60 days depending on carrier underwriting depth
• Compliance ledger setup: 4 to 8 hours of work documenting MSA-by-MSA requirements against the new program

Most of the value of the rebuild comes from closing the AI for products gap (item 3) and the indemnity-cap negotiation (item 7). Those two items alone, in our experience, drive 80% of the actual loss exposure reduction.

A note on this article

The clauses, language examples, and recommendations above reflect typical pharmaceutical sponsor MSAs as encountered in practice. Specific MSAs vary; specific carriers vary; specific state laws vary (Texas in particular has its own quirks around non-subscriber workers comp and additional insured statutes). This is a starting framework, not a coverage opinion. Before binding any program against a specific MSA, run the actual policy language past a broker and the actual indemnity language past counsel.